Overview

Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database

Status:
Completed

Trial end date:
2011-06-01

Target enrollment:

Participant gender:

Summary

This study is conducted in Europe. The purpose of this retrospective study is to collect additional safety information of patients with haemophilia and inhibitors who are treated with rFVIIa.

Details

Lead Sponsor:

Novo Nordisk A/S